Man from Gajuwaka dies of heart attack in Canada
A 30-year-old man from Gajuwaka reportedly died of a heart attack in Canada. The incident came to light after the man’s parents met Gajuwaka MLA and TDP-A.P. president Palla Srinivasa Rao recently and ...
Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk
Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
Armed robbery in Revesby10 天
Canada's Heart Care Gaps Exposed: Study Reveals Inequities
A new study assessing provincial and territorial variations in reimbursement criteria of drug coverage for patients covered by Canada's public ...
Global News24 天
Wegovy approved in Canada to combat risk of non fatal-heart attack
1:38 Wegovy weight loss benefits sustained in longest medical trial to date Wegovy has become the first approved treatment in Canada to address both obesity and the risk of heart-related ...
CBC.ca23 天
Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk
Health Canada has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of non-fatal heart attack, the drug maker says. Novo Nordisk said Wednesday that Wegovy is the first Health ...
Reuters24 天
Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack
Nov 27 (Reuters) - Canada's health regulator has approved Novo Nordisk's (NOVOb.CO), opens new tab weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in ...